Johnson & Johnson

NYSE : JNJ
USA·Healthcare·Drug Manufacturers·Ordinary Shares
$255.56
−1.73 (−0.66%)Oct 16 close
Market Cap
$615.55B
Enterprise Value
$643.82B
P/E (TTM)
29.61
P/B
7.24
Net Cash / (Debt)
−$28.28B
52-Week Range
$186 — $278
5-Year Range
$142 — $278
Avg Volume (3M)
8.16M

Curated managers

11 of 57 hold Johnson & Johnson · holdings at Jun 30, 2026

Manager% of bookChange
Tweedy, Browne Company LLC3.88%Reduced-17.8K
New England Asset Management, Inc.1.65%Reduced-888
Markel Group Inc.
Tom Gayner · Chief Executive Officer
1.18%Unchanged
Fairfax Financial Holdings Limited
Prem Watsa · Chairman and Chief Executive Officer
0.71%Unchanged
Bridgewater Associates, LP
Ray Dalio · Founder (relinquished control of the firm in 2022) (historical)
0.70%Reduced-27.7K
Soros Fund Management LLC
Dawn Fitzpatrick · Chief Executive Officer & Chief Investment Officer
0.11%Reduced-827
Horizon Kinetics Asset Management LLC
Murray Stahl · Co-Founder, Chairman, CEO & CIO (died 2026-04-07) (historical)
0.04%Reduced-201
Semper Augustus Investments Group LLC
Christopher Bloomstran · President and Chief Investment Officer
0.02%New position+794
Baron Capital Group (BAMCO, Inc.)
Ron Baron · Founder, Chief Executive Officer and Portfolio Manager
0.01%Added+2.7K
Gardner Russo & Quinn LLC
Thomas Russo · Managing Member/Chairman
0.00%Reduced-192
Dodge & Cox0.00%Unchanged